Atea Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-87.0M | $-87.0M | $4.0K | $39.6M |
| FY2022 | $-121.0M | $-122.9M | $1.9M | $46.7M |
| FY2023 | $-85.4M | $-85.4M | — | $49.4M |
| FY2024 | $-135.5M | $-135.5M | — | $51.8M |
| FY2025 | $-132.0M | $-132.0M | — | $20.7M |